塩野義薬：FDA Approves XOFLUZA(TM) for the Treatment of Acute Uncomplicated Influenza for People at High Risk of Developing Influenza-Related Complications - 有報キャッチャー

塩野義薬（4507）　FDA Approves XOFLUZA(TM) for the Treatment of Acute Uncomplicated Influenza for People at High Risk of Developing Influenza-Related Complications 2019/10/18

/-

読み込み中…